Drug Shortage Report for ENALAPRILAT INJECTION USP

Last updated on 2024-11-13 History
Report ID 231317
Drug Identification Number 02388499
Brand name ENALAPRILAT INJECTION USP
Common or Proper name ENALAPRILAT INJECTION USP
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ENALAPRILAT
Strength(s) 1.25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2mL vial
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-07-12
Actual start date
Estimated end date 2025-01-31
Actual end date
Shortage status Actual shortage
Updated date 2024-11-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2024-11-13 French Compare
v6 2024-11-13 English Compare
v5 2024-10-11 French Compare
v4 2024-10-11 English Compare
v3 2024-07-13 English Compare
v2 2024-06-26 French Compare
v1 2024-06-26 English Compare

Showing 1 to 7 of 7